IQWiG gives Astellas' Xtandi unprecedentedly positive benefit assessment
This article was originally published in Scrip
Executive Summary
Astellas Pharma, which had already achieved a high IQWiG assessment for Xtandi, has now pulled an even better one out of the bag – gaining an unprecedentedly positive outcome from the hard-to-please German HTA authority.